Abstract
Objective: To understand the relationship between covid-19 and systemic arterial hypertension. Review bibliographic: Coronavirus enters cells through the ACE II receptor. At the same time, patients with SAH have these receptors in greater quantity. Thus, they would be more vulnerable to the advance of the virus in extrapulmonary cells. Thus, an increase in covid-19 morbidity and mortality was observed in patients with SAH. Most deaths and complications are in patients aged 60 years or older who have some comorbidity. In addition, it is important to understand the correlation between covid-19 and SAH and why this comorbidity generates a worse prognosis in patients infected with coronavirus. First, so that behaviors that prevent contamination in this risk group are more effective, as well as to optimize the treatment of hypertension in order to avoid complications in the health of patients. Final considerations: Hypertension has a significant association with covid-19 severity and mortality. Hypertensive and coronavirus-infected patients may present with severe clinical manifestations and complications in target organs.